International Biotechnology Trust PLC 13F 持仓 · 最近申报 2023年Q3
International Biotechnology Trust 在 2023年Q3（报告期截至 2023-09-30）的 SEC 13F 申报中报告了 65 只证券，申报市值合计 2.97 亿美元。前几大持仓：AMGN（7.17%）、INCY（6.97%）、GILD（5.90%）。本季前 25 大持仓中：增持 12 只、减持 8 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC COM | $21.3M | 7.17% | 79,246 | 减持 |
| 2 | INCY | INCYTE CORP INC COM | $20.7M | 6.97% | 358,454 | 持平 |
| 3 | GILD | GILEAD SCIENCES INC COMMO | $17.5M | 5.90% | 233,584 | 增持 |
| 4 | ITCI | INTRA-CELLULAR THERAPIES | $16.5M | 5.57% | 317,856 | 增持 |
| 5 | BMRN | BIOMARIN PHARMACEUTICAL I | $13.6M | 4.58% | 153,656 | 增持 |
| 6 | SUPN | SUPERNUS PHARMACEUTICALS | $11.8M | 3.96% | 426,500 | 减持 |
| 7 | VERA | VERA THERAPEUTICS | $10.4M | 3.50% | 758,355 | 减持 |
| 8 | BIIB | BIOGEN INC COMMON STOCK | $10.3M | 3.48% | 40,200 | 增持 |
| 9 | HRMY | Harmony Biosciences Holdi | $10.3M | 3.47% | 314,500 | 减持 |
| 10 | MRTX | MIRATI THERAPEUTICS INC C | $9.4M | 3.17% | 216,000 | 减持 |
| 11 | RARE | ULTRAGENYX PHARMACEUTICAL | $8.9M | 3.00% | 250,052 | 增持 |
| 12 | QURE | UNIQURE N.V. COM EUR0.05 | $8.3M | 2.81% | 1.2M | 增持 |
| 13 | AUPH | AURINIA PHARMACEUTICALS I | $8.1M | 2.72% | 1.0M | 增持 |
| 14 | UTHR | UNITED THERAPEUTICS CORP | $7.7M | 2.58% | 33,959 | 减持 |
| 15 | VRTX | VERTEX PHARMACEUTICALS IN | $7.3M | 2.46% | 21,000 | 持平 |
| 16 | REGN | REGENERON PHARMACEUTICALS | $7.3M | 2.45% | 8,847 | 减持 |
| 17 | ILMN | ILLUMINA INC COM | $6.9M | 2.34% | 50,500 | 持平 |
| 18 | ALNY | ALNYLAM PHARMACEUTICALS I | $6.5M | 2.20% | 36,800 | 减持 |
| 19 | AMLX | AMYLYX PHARMS. | $5.4M | 1.82% | 295,000 | 增持 |
| 20 | KRYS | KRYSTAL BIOTECH INC COM | $5.3M | 1.80% | 46,092 | 增持 |
| 21 | KRTX | KARUNA THERAPEUTICS INC C | $5.2M | 1.74% | 30,500 | 增持 |
| 22 | AXSM | AXSOME THERAPEUTICS INC. | $4.1M | 1.37% | 58,300 | 持平 |
| 23 | ERAS | ERASCA INC COM | $3.8M | 1.28% | 1.9M | 增持 |
| 24 | ACAD | ACADIA PHARMACEUTICALS IN | $3.7M | 1.26% | 179,702 | 增持 |
| 25 | RVNC | REVANCE THERAPEUTICS INC | $3.3M | 1.11% | 288,726 | 持平 |
来源：SEC 13F 申报文件 · 截至 2023-09-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR